Likewise, the inclusion of a plasma-based neurodegeneration biomarker such as plasma neurofilament light chain,28 while not specific for Alzheimer’s disease, may also improve prognostic capacity. Here, NEFL is linked to early-onset autosomal dominant Alzheimer disease.